1-3 of 3
Adam Boyd
Close
Sort by
Journal Articles

Correlation Between Baseline Methylmalonic Acid Status and Mucositis Severity in the PROPEL Study: Implications for Vitamin Prophylaxis.

Barbara Pro, MD, Bertrand Coiffier, MD, Steven M. Horwitz, MD, Adam Boyd, PhD, Ellen Neylon, RN, Steven Fruchtman, MD, Owen A O'Connor, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1681.
https://doi.org/10.1182/blood.V114.22.1681.1681
Published: 2009
Journal Articles

Stem Cell Transplant (SCT) and Pralatrexate Therapy: Outcome of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Who Received SCT Prior to or Following Pralatrexate Therapy.

Leslie Popplewell, MD, Barbara Pro, MD, Eric Jacobsen, MD, Steven M. Horwitz, MD, Adam Boyd, PhD, Molly Patterson, BA, Steven Fruchtman, MD, Owen A O'Connor, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3420.
https://doi.org/10.1182/blood.V114.22.3420.3420
Published: 2009
Journal Articles

PROPEL: A Multi-Center Phase 2 Open-Label Study of Pralatrexate (PDX) with Vitamin B 12 and Folic Acid Supplementation in Patients with Replapsed or Refractory Peripheral T-Cell Lymphoma

Owen A. O’Connor, MD, PhD, Barbara Pro, M.D., Lauren Pinter-Brown, MD, Leslie Popplewell, MD, Nancy Barlett, MD, Andrei Shustov, MD, Mary Jo Lechowicz, MD, Kerry J Savage, MD, MSc, Bertrand Coiffier, MD, Eric Jacobsen, MD, Pier Luigi Zinzani, MD, Andre Goy, MD, Jasmine Zain, MD, Shannon Wilroy, Molly Patterson, Adam Boyd, Michael E. Saunders, MD, Pablo Cagnoni, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2008) 112 (11): 261.
https://doi.org/10.1182/blood.V112.11.261.261
Published: 2008